These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30149048)

  • 1. Synergistic inhibition of aggressive breast cancer cell migration and invasion by cytoplasmic delivery of anti-RhoC silencing RNA and presentation of EPPT1 peptide on "smart" particles.
    Kaushal N; Tiruchinapally G; Durmaz YY; Bao L; Gilani R; Merajver SD; ElSayed MEH
    J Control Release; 2018 Nov; 289():79-93. PubMed ID: 30149048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
    Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
    Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.
    Wu M; Wu ZF; Rosenthal DT; Rhee EM; Merajver SD
    Cancer; 2010 Jun; 116(11 Suppl):2768-82. PubMed ID: 20503409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
    Wu D; Asiedu M; Wei Q
    Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells].
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):251-7. PubMed ID: 26462888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
    Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E
    Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of RhoC induces macrophage M1 polarization to inhibit migration and invasion in colon cancer via regulating the PTEN/FOXO1 pathway.
    Yang B; Wang L; Tian Z
    Int J Exp Pathol; 2023 Feb; 104(1):33-42. PubMed ID: 36576072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of expression of RhoC with invasiveness of breast cancer cells in vitro].
    Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):898-903. PubMed ID: 18478927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1.
    Lin M; DiVito MM; Merajver SD; Boyanapalli M; van Golen KL
    Mol Cancer; 2005 Jun; 4(1):21. PubMed ID: 15969750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathway.
    Hu Y; Liu H; Zhu Z; Qi X; Yuan W; Tian M; Wang D; Xu J
    Biochem Biophys Res Commun; 2022 Nov; 629():17-25. PubMed ID: 36088805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA 10b promotes abnormal expression of the proto-oncogene c-Jun in metastatic breast cancer cells.
    Knirsh R; Ben-Dror I; Modai S; Shomron N; Vardimon L
    Oncotarget; 2016 Sep; 7(37):59932-59944. PubMed ID: 27494896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoC is essential for the metastasis of gastric cancer.
    Liu N; Zhang G; Bi F; Pan Y; Xue Y; Shi Y; Yao L; Zhao L; Zheng Y; Fan D
    J Mol Med (Berl); 2007 Oct; 85(10):1149-56. PubMed ID: 17549441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
    Zuo Y; Wu Y; Chakraborty C
    J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mucin1 Aptamer-Conjugated Chitosan Nanoparticles for Targeted Co-Delivery of Docetaxel and IGF-1R siRNA to SKBR3 Metastatic Breast Cancer Cells.
    Jafari R; Majidi Zolbanin N; Majidi J; Atyabi F; Yousefi M; Jadidi-Niaragh F; Aghebati-Maleki L; Shanehbandi D; Soltani Zangbar MS; Rafatpanah H
    Iran Biomed J; 2019 Jan; 23(1):21-33. PubMed ID: 30041514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.
    Shen J; Sun H; Xu P; Yin Q; Zhang Z; Wang S; Yu H; Li Y
    Biomaterials; 2013 Feb; 34(5):1581-90. PubMed ID: 23146437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.